Biography
Dr. José Serna is the Medical Director of IVI Zaragoza where he combines his management duties with his medical practice. He obtained his M.D. degree in 1993 at the Hospital Militar Universitario del Ejercito del Aire, Universidad Complutense de Madrid. During his last year at school, he pursued his enthusiasm in biology and basic research and was enrolled in the Growth Factor Laboratory at the Developmental Biology Department at Centro de Investigaciones Biológicas (CSIC) in Madrid. After competing medical school, he gained a predoctoral fellowship to investigate the role of insulin family of growth factors in embryo development. He then obtained his Ph.D. in Molecular Biology and Biochemistry and moved forward in basic research obtaining a Marie Curie Post-doctoral Fellowship fulfilling simultaneously clinical training and basic research in the Pediatrics Department at St. Bartholomew Hospital in London.
Read more
Education and Training
MD | Universidad Complutense de Madrid (1993) |
Fellowship | Centro de Investigaciones Biológicas. Consejo Superior de Investigaciones Científicas (CSIC) Madrid. (1998) |
PhD | Department of Biochemistry and Molecular Biology. Universidad Complutense de Madrid (1998) |
Postdoctoral | Dpt. Pediatrics. Saint Bartholomew Hospital. London (1999) |
SUD | Reproductive Medicine. Universidad Nacional de Educación a Distancia (2003) |
Residency | Fundación Jiménez Díaz. Madrid (2006) |
Publications
-
Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure.
Alecsandru D Barrio A Andia V Cruz E Aparicio P Serna J Cruz M Pellicer A García-Velasco JA
PLoS One, 13(10):NA-NA, 2018. -
Pros and cons of implementing a carrier genetic test in an infertility practice
Gil-Arribas E Herrer R Serna J
Curr Opin Obstet Gynecol, 28(3):172–7, 2016. -
Effects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro.
Gamundi-Segura S Serna J Oehninger S Horcajadas J Arbones-Mainar J
J Physiol Biochem 71(3):537–46, 2015. -
Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature.
Fauser B Devroey P Diedrich K Balaban B Bonduelle M de Waal HAD Estella C Ezcurra D Geraedts JP Howles CM Lerner-Geva L Serna J Wells D
Reprod Biomed Online, 28:162–182, 2014. -
An engaging example of translational medicine: the Wnt/?-catenin cellular pathway and pharmacological research in fibroid treatment.
Serna J
Fertil Steril, 101(5):1254, 2014. -
Manejo expectante de las gestaciones de localización desconocida después de una técnica de reproducción asistida: Manejo clínico, pronóstico y complicaciones asociadas.
Puente J Serna J Martínez M Muñoz J Pacheco A García-Velasco JA
Reproducción, 27(3):126-33 2012. -
Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J Cholquevilque JL Cela V Martínez-Salazar J Requena A García-Velasco JA
Fertil Steril. 90:2190-5, 2008. -
Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B Barrio A Pacheco A Serna J Zuzuarregui JL García-Velasco JA
Fertil Steril, 90(5):1579–82, 2008. -
New trends in IVF. Is there any evidence?
Serna J Pellicer A
In: Controversies in Obstetrics Gynecology and Infertility, 141–4, 2005. -
Effect of repeated assisted reproduction techniques on the ovarian response.
Serna J García-Velasco JA
Curr Opin Obstet Gynecol. 17:233-6, 2005.
Read more